BKGI Stock Overview
Provides medical analysis services in Thailand. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Bangkok Genomics Innovation Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿2.00 |
| 52 Week High | ฿5.65 |
| 52 Week Low | ฿1.67 |
| Beta | 0 |
| 1 Month Change | -8.26% |
| 3 Month Change | -2.91% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -54.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| BKGI | TH Healthcare | TH Market | |
|---|---|---|---|
| 7D | 0.5% | 1.5% | -0.6% |
| 1Y | n/a | -25.6% | -16.9% |
Return vs Industry: Insufficient data to determine how BKGI performed against the TH Healthcare industry.
Return vs Market: Insufficient data to determine how BKGI performed against the TH Market.
Price Volatility
| BKGI volatility | |
|---|---|
| BKGI Average Weekly Movement | 9.6% |
| Healthcare Industry Average Movement | 4.8% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in TH Market | 10.3% |
| 10% least volatile stocks in TH Market | 2.3% |
Stable Share Price: BKGI's share price has been volatile over the past 3 months compared to the TH market.
Volatility Over Time: BKGI's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of TH stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | n/a | www.bangkokgenomics.com |
Bangkok Genomics Innovation Public Company Limited provides medical analysis services in Thailand. The company offers screening for fetal chromosomal abnormalities using non-invasive prenatal testing under the NIFTY brand; preimplantation chromosomal abnormality and thalassemia carrier gene screening; infectious disease group analysis; testing for human papilloma virus; and monkeypox virus, COVID-19 Pathogen, and COVID-19 pathogen immunity testing. It also provides other screening tests, such as cancer-related gene screening to predict the risk of inherited cancer, to monitor treatment and select drugs that are appropriate for one's genetics, and to provide treatment and disease prevention.
Bangkok Genomics Innovation Public Company Limited Fundamentals Summary
| BKGI fundamental statistics | |
|---|---|
| Market cap | ฿1.20b |
| Earnings (TTM) | ฿50.17m |
| Revenue (TTM) | ฿337.59m |
23.9x
P/E Ratio3.6x
P/S RatioIs BKGI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BKGI income statement (TTM) | |
|---|---|
| Revenue | ฿337.59m |
| Cost of Revenue | ฿197.52m |
| Gross Profit | ฿140.08m |
| Other Expenses | ฿89.91m |
| Earnings | ฿50.17m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.084 |
| Gross Margin | 41.49% |
| Net Profit Margin | 14.86% |
| Debt/Equity Ratio | 0% |
How did BKGI perform over the long term?
See historical performance and comparisonDividends
2.5%
Current Dividend Yield57%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/17 06:16 |
| End of Day Share Price | 2025/03/17 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bangkok Genomics Innovation Public Company Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mintra Rattayapas | Krungsri Securities Public Company Limited |